Financial report interval: 2025.12.31 - 2026.03.31
Preview: Arbutus Pharma(ABUS) predict that the Revenue is 176.45 M (+101 times%), Beat estimate;the EBIT is 166.39 M (+763.4%), Beat estimate;the EPS is 0.857 (+775.5%), Beat estimate.